You are here

Electrophysiology & Arrhythmia

 

More communities have started to place AEDs in public locations. Still, a recent Canadian study showed those initiatives might not be enough to provide people with a better chance to survive cardiac arrests.

A recent retrospective, population-based cohort study in Canada showed that proximity to an AED might not always lead to using the device. More than 20 percent of out-of-hospital cardiac arrests occurred near a public AED that was inaccessible at the time of the arrest.

CIEDs with remote monitoring capabilities can provide a wealth of information, yet some physicians and hospitals aren’t making the most of this resource.

The American College of Cardiology (ACC) and American Heart Association (AHA) released updated clinical performance and quality measure sets on June 27 for adults with atrial fibrillation or atrial flutter.

Five electrophysiologists joined Cardiovascular Business editorial advisor Matthew R. Reynolds, MD, SM, for a discussion about how they will deliver quality care to a growing number of atrial fibrillation patients even as the U.S. healthcare system turns its focus from volume to value.

 

 

Recent Headlines

Texas hospital first to use new heart catheter device

The Texas Cardiac Arrhythmia Institute at St. David’s Medical Center in Austin, Texas, was the first facility in the country to use a new heart catheter device approved by the FDA in August.

Most patients taking warfarin do not have stable long-term INR values

During a six-month period, only 26 percent of patients taking warfarin to treat atrial fibrillation had stable international normalized ratio (INR) values, according to a registry analysis. In addition, only 34 percent of those patients continued to have stable INR values in the following year.

AEDs are often inaccessible following out-of-hospital cardiac arrests

More communities have started to place AEDs in public locations. Still, a recent Canadian study showed those initiatives might not be enough to provide people with a better chance to survive cardiac arrests.

Registry analysis shows atrial fib patients who take dabigatran etexilate have low risk of stroke, bleeding

A registry analysis found that patients with non-valvular atrial fibrillation who received dabigatran etexilate (Pradaxa) had low rates of stroke, major bleeding and life-threatening bleeding after two years of treatment.

Updated results confirm safety, efficacy of the Micra transcatheter pacing system

After 12 months of follow-up, 96 percent of patients who received the Micra transcatheter pacing system (Medtronic) had no major complications.

Patients with nonischemic heart failure may not benefit from ICD implantation

For patients with systolic heart failure that was not caused by ischemic heart disease, implanting prophylactic implantable cardioverter-defibrillators (ICDs) did not reduce the long-term rate of death of any cause compared with patients who did not receive an ICD, according to a randomized trial.

Inaccessibility to AEDs may hinder survival following out-of-hospital cardiac arrests

A recent retrospective, population-based cohort study in Canada showed that proximity to an AED might not always lead to using the device. More than 20 percent of out-of-hospital cardiac arrests occurred near a public AED that was inaccessible at the time of the arrest.

Not So Far Away? Moving Remote Cardiac Implantable Electronic Device Monitoring Closer to its Full Potential

CIEDs with remote monitoring capabilities can provide a wealth of information, yet some physicians and hospitals aren’t making the most of this resource.

ACC, AHA release updated measure sets for atrial fibrillation

The American College of Cardiology (ACC) and American Heart Association (AHA) released updated clinical performance and quality measure sets on June 27 for adults with atrial fibrillation or atrial flutter.

Abbott presents positive findings of three trials evaluating its RhythmView technology for atrial fibrillation

Patients with atrial fibrillation had positive results after receiving treatment with focal impulse rotor modulation (FIRM)-guided rotor ablation, according to three studies presented at the recent Cardiostim-EHRA Europace conference in Nice, France.

Pages